Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Development of a series wrapping cam mechanism for energy transfer in wearable arm support applications.

Schroeder JS, Perry JC.

IEEE Int Conf Rehabil Robot. 2017 Jul;2017:585-590. doi: 10.1109/ICORR.2017.8009311.

PMID:
28813883
2.

Design of a spring-assisted exoskeleton module for wrist and hand rehabilitation.

Perry JC, Trimble S, Castilho Machado LG, Schroeder JS, Belloso A, Rodriguez-de-Pablo C, Keller T.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:594-597. doi: 10.1109/EMBC.2016.7590772.

PMID:
28268400
3.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

PMID:
15505095
4.

Emerging therapies for angina: new modalities may offer additional clinical options.

Schroeder JS.

Manag Care Interface. 2004 Apr;17(4):45-52.

PMID:
15108760
5.

Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease.

Kato T, Chan MC, Gao SZ, Schroeder JS, Yokota M, Murohara T, Iwase M, Noda A, Hunt SA, Valantine HA.

J Am Coll Cardiol. 2004 Mar 17;43(6):1034-41.

6.

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.

JAMA. 2003 May 28;289(20):2685-94.

PMID:
12771115
7.

Infectious burden and atherosclerosis.

Schroeder JS.

Curr Cardiol Rep. 2002 Jul;4(4):259. No abstract available.

PMID:
12052264
8.

Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial.

Theroux P, Chaitman BR, Erhardt L, Jessel A, Meinertz T, Nickel WU, Schroeder JS, Tognoni G, White H, Willerson JT.

Curr Control Trials Cardiovasc Med. 2000;1(1):59-67.

9.

Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease.

Giannetti N, Herity NA, Alimollah A, Gao SZ, Schroeder JS, Yeung AC, Hunt SA, Valantine HA.

Clin Transplant. 2001 Aug;15(4):247-52.

PMID:
11683818
10.

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.

Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson JT, Jessel A.

Circulation. 2000 Dec 19;102(25):3032-8.

PMID:
11120691
11.

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW Jr, Merigan TC, Schroeder JS.

Circulation. 1999 Jul 6;100(1):61-6.

PMID:
10393682
12.

HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?

Valantine HA, Schroeder JS.

Circulation. 1997 Sep 2;96(5):1370-3. No abstract available.

PMID:
9315517
13.
14.

Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study.

Lim TT, Liang DH, Botas J, Schroeder JS, Oesterle SN, Yeung AC.

Circulation. 1997 Feb 18;95(4):855-9.

PMID:
9054742
15.

Prediction of angiographic disease by intracoronary ultrasonographic findings in heart transplant recipients.

Liang DH, Gao SZ, Botas J, Pinto FJ, Schroeder JS, Alderman EL, Yeung AC.

J Heart Lung Transplant. 1996 Oct;15(10):980-7.

PMID:
8913914
16.

Early development of accelerated graft coronary artery disease: risk factors and course.

Gao SZ, Hunt SA, Schroeder JS, Alderman EL, Hill IR, Stinson EB.

J Am Coll Cardiol. 1996 Sep;28(3):673-9.

17.

Overexpression and mutations of p53 in metastatic malignant melanomas.

Hartmann A, Blaszyk H, Cunningham JS, McGovern RM, Schroeder JS, Helander SD, Pittelkow MR, Sommer SS, Kovach JS.

Int J Cancer. 1996 Jul 29;67(3):313-7.

18.

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.

Haywood GA, Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, Vagelos R, Oyer P, Fowler MB.

Heart. 1996 May;75(5):455-62.

19.

Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.

Rickenbacher PR, Trindade PT, Haywood GA, Vagelos RH, Schroeder JS, Willson K, Prikazsky L, Fowler MB.

J Am Coll Cardiol. 1996 Apr;27(5):1192-7.

20.

Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

Rickenbacher PR, Kemna MS, Pinto FJ, Hunt SA, Alderman EL, Schroeder JS, Stinson EB, Popp RL, Chen I, Reaven G, Valantine HA.

Transplantation. 1996 Jan 15;61(1):46-53.

PMID:
8560573
21.

Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.

Rickenbacher PR, Pinto FJ, Lewis NP, Hunt SA, Alderman EL, Schroeder JS, Stinson EB, Brown BW, Valantine HA.

Circulation. 1995 Dec 15;92(12):3445-52.

PMID:
8521566
22.

Recent advances in cardiac transplantation.

Valantine HA, Schroeder JS.

N Engl J Med. 1995 Sep 7;333(10):660-1. No abstract available.

PMID:
7637732
23.
24.

Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study.

Botas J, Pinto FJ, Chenzbraun A, Liang D, Schroeder JS, Oesterle SN, Alderman EL, Popp RL, Yeung AC.

Circulation. 1995 Sep 1;92(5):1126-32.

PMID:
7648656
25.

Absent thoracolumbar spine: prenatal sonography of a new lethal skeletal anomaly.

Horrow MM, Schroeder JS, Schneider A, Zaeri N.

J Ultrasound Med. 1995 Sep;14(9):711-3. No abstract available.

PMID:
7500442
26.

Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography.

Rickenbacher PR, Pinto FJ, Lewis NP, Hunt SA, Gamberg P, Alderman EL, Schroeder JS, Valantine HA.

Am J Cardiol. 1995 Aug 15;76(5):340-5.

PMID:
7639157
27.

Accelerated graft coronary artery disease in heart-transplant recipients.

Schroeder JS, Gao SZ.

Coron Artery Dis. 1995 Mar;6(3):226-33. Review. No abstract available.

PMID:
7788035
28.

Giant cell myocarditis.

Cooper LT Jr, Berry GJ, Rizeq M, Schroeder JS.

J Heart Lung Transplant. 1995 Mar-Apr;14(2):394-401.

PMID:
7779862
29.

Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound.

Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL, Valantine HA, Hunt SA, Schroeder JS, Popp RL, et al.

J Am Coll Cardiol. 1995 Jan;25(1):171-7.

30.

Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study.

Chenzbraun A, Pinto FJ, Alderman EL, Botas J, Oesterle SN, Schroeder JS, Valantine H, Popp RL.

J Am Soc Echocardiogr. 1995 Jan-Feb;8(1):1-8.

PMID:
7710741
31.

Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients.

Pinto FJ, Chenzbraun A, Botas J, Valantine HA, St Goar FG, Alderman EL, Oesterle SN, Schroeder JS, Popp RL.

Circulation. 1994 Nov;90(5):2348-55.

PMID:
7955193
32.

Does rapidity of development of transplant coronary artery disease portend a worse prognosis?

Gao SZ, Hunt SA, Schroeder JS, Alderman E, Hill IR, Stinson EB.

J Heart Lung Transplant. 1994 Nov-Dec;13(6):1119-24.

PMID:
7865519
33.

Indications for cardiac transplantation.

Schroeder JS.

Heart Dis Stroke. 1994 Nov-Dec;3(6):345-9. No abstract available.

PMID:
7850155
34.

Cardiac transplantation: the Stanford experience in the cyclosporine era.

Sarris GE, Moore KA, Schroeder JS, Hunt SA, Fowler MB, Valantine HB, Vagelos RH, Billingham ME, Oyer PE, Stinson EB, et al.

J Thorac Cardiovasc Surg. 1994 Aug;108(2):240-51; discussion 251-2.

35.

Metabolic risk factors for atherosclerosis in heart transplant recipients.

Kemna MS, Valantine HA, Hunt SA, Schroeder JS, Chen YD, Reaven GM.

Am Heart J. 1994 Jul;128(1):68-72.

PMID:
8017286
36.

Unusual forms of ischemic heart disease.

Drexler H, Schroeder JS.

Curr Opin Cardiol. 1994 Jul;9(4):457-64. Review.

PMID:
7919590
37.

Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis.

Gao SZ, Schroeder JS, Hunt SA, Valantine HA, Hill IR, Stinson EB.

J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):1029-35.

PMID:
8312304
38.

Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography.

Pinto FJ, St Goar FG, Gao SZ, Chenzbraun A, Fischell TA, Alderman EL, Schroeder JS, Popp RL.

Circulation. 1993 Oct;88(4 Pt 1):1709-14.

PMID:
8403316
39.

A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

Schroeder JS, Gao SZ, Alderman EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederhold V, Stinson EB.

N Engl J Med. 1993 Jan 21;328(3):164-70.

40.
41.

Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation.

Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, Stinson EB.

J Heart Lung Transplant. 1992 Sep-Oct;11(5):892-901.

PMID:
1420237
42.

Accelerated graft coronary artery disease: diagnosis and prevention.

Schroeder JS, Gao SZ, Hunt SA, Stinson EB.

J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 2):S258-65. Review.

PMID:
1515448
43.

Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening.

St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ, Stinson EB, Popp RL.

Circulation. 1992 Mar;85(3):979-87.

PMID:
1537134
44.

The influence of preoperative patient characteristics on early and late survival following cardiac transplantation.

Costard-Jäckle A, Hill I, Schroeder JS, Fowler MB.

Circulation. 1991 Nov;84(5 Suppl):III329-37.

PMID:
1934427
45.

Characteristics of serial electrocardiograms in heart transplant recipients.

Gao SZ, Hunt SA, Wiederhold V, Schroeder JS.

Am Heart J. 1991 Sep;122(3 Pt 1):771-4.

PMID:
1877454
46.

The antiatherogenic effects of calcium antagonists.

Keogh AM, Schroeder JS.

Am J Hypertens. 1991 Jul;4(7 Pt 2):512S-518S. Review.

PMID:
1654938
47.

Chest pain in heart-transplant recipients.

Schroeder JS, Hunt SA.

N Engl J Med. 1991 Jun 20;324(25):1805-7. No abstract available.

PMID:
2038369
48.

Transplant coronary artery disease: histopathologic correlations with angiographic morphology.

Johnson DE, Alderman EL, Schroeder JS, Gao SZ, Hunt S, DeCampli WM, Stinson E, Billingham M.

J Am Coll Cardiol. 1991 Feb;17(2):449-57.

49.

Increased rejection in gender-mismatched grafts: amelioration by triple therapy.

Keogh AM, Valantine HA, Hunt SA, Schroeder JS, Oyer PE.

J Heart Lung Transplant. 1991 Jan-Feb;10(1 Pt 1):106-10.

PMID:
2007161
50.

Rapid histological changes in endomyocardial biopsy specimens after myocarditis.

Keogh AM, Billingham ME, Schroeder JS.

Br Heart J. 1990 Dec;64(6):406-8.

Supplemental Content

Loading ...
Support Center